- Rating
- 2(+1)
- Confidence
- 4
- Informativeness
- 2(+1)
- Presentation
- 1
- Soundness
- 2
Read review
Paper summary
This study presents AbGate, a parameter-efficient framework for generating antibody candidates conditioned solely on antigen sequence, without prior knowledge of the binding site or antibody–antigen interface geometry. AbGate uses a learned pooler to compress variable-length antigen sequences into 32 tokens, which are supplied to every layer of a pretrained antibody language model through cross-attention. With approximately 1.1% of the trainable parameters used by a fully fine-tuned baseline. Experimentally, AbGate achieves comparable mean RosettaFold3 ipTM and pLDDT scores on a shared target.
Critical strengths
-
This paper addresses the design of antibody sequences directly from antigen sequences without annotated binding sites. To incorporate antigen information into the biological language model responsible for antibody design, the authors encode variable-length antigen sequences and compress their representations into a fixed number of tokens. This is an interesting and reasonable approach to conditioning antibody generation on antigen sequence information.
-
Although the experimental section provides limited quantitative analysis, the authors include a range of statistical plots to support the strong performance of AbGate despite its relatively small number of trainable parameters.
Critical weaknesses
-
Research scope. Designing antibodies from antigen sequences alone, without incorporating 3D structural information or binding-site annotations, represents a relatively unconstrained formulation of conditional antibody design. While scientifically relevant, the practical utility of this setting for future drug-design applications may be limited.
-
Methodological innovation. Encoding variable-length antigen sequences into a fixed number of token representations is a reasonable and efficient way to provide antigen context to an antibody generation model. However, the generation component still relies on a pretrained foundation model, and cross-attention is a well-established mechanism for integrating conditioning features. The approach can therefore be viewed as a parameter-efficient fine-tuning (PEFT) adaptation to the certain setting, with limited methodological novelty.
-
Experimental evaluation. The paper reports relatively few numerical performance metrics, relying more heavily on statistical visualizations to support its conclusions. Although these analyses are varied, they do not, on their own, provide sufficiently strong evidence to establish the superiority of AbGate.
Questions for authors
I suggest the authors will more clearly articulate the methodological novelty of their proposed approach and provide more comprehensive quantitative evaluations to substantiate AbGate’s claimed advantages.
3 comments
I thank the authors for their response. The additional experiments and analyses have helped clarify the positioning and effectiveness of the proposed method. However, the premise of excluding 3D structural information, together with the reliance on additional pretrained foundation models, limits its further practical applicability. Taking these considerations into account, I have decided to raise my rating score to 2.
Thank you for taking another look at our work. Your questions helped us explain more clearly what AbGate contributes and how our results support it.
We appreciate your request for a clearer account of AbGate's contribution and stronger quantitative support. We have tried our best to revise the paper to improve the presentation accordingly and the revision explains the role of the conditioning interface and adds comparisons that assess its response to antigen input and its parameter efficiency.
Scope and practical role. Specifically, AbGate is a sequence-based only antibody design method and learns from antibody–antigen sequence pairs without the need to have resolved complex structures and generates candidates for subsequent structural screening. AbGate, compared to existing methods, is more scalable and efficient when considering conditioning on long antigen sequences for targeted antibody design with no structure information available. To clarify its practical role, the revised Discussion connects this stage to future evaluation against experimental binding data, with the aim of improving candidate selection for laboratory testing.
Methodological contribution. Besides focusing on sequence-based conditional antibody design, AbGate adopts a parameter-efficient fine-tuning (PEFT) adaptation strategy with the corresponding design of a fixed decoder interface for antigens of different lengths as well as customized cross-attention conditioning mechanism. Our hypothesis is that learned pooling can retain features relevant to antigen recognition within 32 tokens, while cross-attention lets each decoder layer retrieve features relevant to the antibody sequence being generated. The decoder receives the same number of antigen tokens for every target, without consuming autoregressive input positions.
The architectural length decoupling in AbGate is a unique feature. With the identified potential bias due to the length dependence of predictor scores in the tested baselines through our presented comparisons within each antigen and across length groups, we showed that a single trained AbGate model can produce candidates across 502 held-out antigens without separate finetuning for each antigen family, with mean confidence close to known binders across length groups and several families absent from training. This demonstrates the effectiveness of the learned interface across targets by AbGate while the pretrained decoder blocks remain frozen.
Quantitative evidence. To address your request for stronger quantitative support, we added the conditioning and architecture comparisons in Section 3.4. Below, we summarize these additions alongside the MAGE and held-out generation results already reported in Sections 3.2–3.3. Together, they show the parameter efficiency of AbGate, the quality of its generated candidates, and its response to antigen input.
Similar mean confidence with fewer trainable parameters. On the shared RBD, AbGate uses 8.46M trainable parameters compared with MAGE’s 764M. Mean ipTM is 0.434 versus 0.435, and mean pLDDT is 0.787 versus 0.789.
A smaller conditioning architecture with higher sequence retention. In Section 3.4, AbGate uses 8.46M trainable parameters, compared with 12.44M for mean pooling and 15.21M for K32 pooling with vector adapters. Their mean ipTM scores are nearly identical, ranging from 0.470 to 0.472. AbGate has the highest filter pass rate, at 95.2%, compared with 92.0% and 94.1%. Each architecture generates 6,000 candidates, with three passing designs per target evaluated across 99 targets.
Generation across diverse held-out antigens. Across 502 targets, 95.6% of candidates pass the sequence filters. None of the pairs passing the numbering and length checks exactly duplicates a training pair. The interquartile ranges overlap with held-out antibodies across all seven predicted DeepSP properties. In the separate 496-target matched panel, mean ipTM is 0.460 for AbGate and 0.471 for known binders, while mean pLDDT is 0.787 and 0.788.
A measurable response to antigen input. Across 100 targets, replacing the antigen changes generated CDR3 distributions more than repeated sampling does on average, with mean ΔMMD² = 5.69 × 10⁻⁴. CDR3 loops contribute to antigen recognition, so this result shows that antigen input affects a relevant part of the generated antibody sequence.
These results support a small trainable interface that responds to antigen input while maintaining candidate quality and similar mean structural confidence. The revised Discussion also identifies the need to strengthen computational evaluation against experimental outcomes, alongside future comparisons with unconditional generators and exploration of reinforcement learning.
We would appreciate your reconsideration of the quantitative support for AbGate’s contribution, taking these new comparisons together with the results already reported in Sections 3.2–3.3.